This $1,400,500.00 Project Grant was awarded on August 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute For Research (PAVIR), a nonprofit foundation. The funding will support PAVIR's research efforts over a 3-year period ending on August 14, 2026 to investigate the role of inflammatory astrocyte reactivity in mild traumatic brain injury. PAVIR has extensive experience conducting medical research...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
This $997,008 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports a 3-year research project by the Northern California Institute for Research and Education, Inc. (NCIRE) to investigate risk and resilience factors for Alzheimer's disease and related dementias (ADRD) among American Indian and Alaskan Native veterans. The research aims to inform prevention strategies for this population. NCIRE is a...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The Defense Health Agency awarded a $6,325,327 project grant to the Tampa VA Research and Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420) to improve health care access and engagement for veterans and service members with traumatic brain injury morbidity over a 4-year period ending on September 29, 2027. As the prime grantee, the foundation will provide data identification, extraction, natural language processing, and data transformation...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $1,437,598 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, effective September 1, 2024 through August 31, 2027, will fund the "TRANSFORMING RESEARCH AND CLINICAL KNOWLEDGE IN TRAUMATIC BRAIN INJURY: CONCUSSION OUTCOME AND RECOVERY PREDICTION SCORE (TRACK-TBI: CORPS)" project. This research initiative aims...
The Defense Health Agency awarded a $183,258 Project Grant to the East Bay Institute for Research & Education Inc., a non-profit organization located in Mather, California. The grant, provided under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports a longitudinal study monitoring cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The research project, with a performance period from March 1, 2025 to...
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
This federal Project Grant award of $737,899 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Texas Health Science Center at San Antonio to develop a non-trauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The award has a performance period from September 1, 2024 to August 31, 2027. The project aims to...
This $5,954,349.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a randomized controlled trial to optimize heart rate variability treatment for combat veterans and service members with persistent post-concussion symptoms. The prime awardee, Virginia Commonwealth University, is collaborating with two sub-awardees, the Palo Alto Veterans Institute for Research and the Richmond Institute for Veterans Research,...